Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Aug 11:370:m2724.
doi: 10.1136/bmj.m2724.

Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study

Affiliations
Multicenter Study

Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study

Nicklas Vinter et al. BMJ. .

Abstract

Objective: To assess temporal trends in the association between newly diagnosed atrial fibrillation and death.

Design: Community based cohort study.

Setting: Framingham Heart Study cohort, in 1972-85, 1986-2000, and 2001-15 (periods 1-3, respectively), in Framingham, MA, USA.

Participants: Participants with no atrial fibrillation, aged 45-95 in each time period, and identified with newly diagnosed atrial fibrillation (or atrial flutter) during each time period.

Main outcome measures: The main outcome was all cause mortality. Hazard ratios for the association between time varying atrial fibrillation and all cause mortality were calculated with adjustment for time varying confounding factors. The difference in restricted mean survival times, adjusted for confounders, between participants with atrial fibrillation and matched referents at 10 years after a diagnosis of atrial fibrillation was estimated. Meta-regression was used to test for linear trends in hazard ratios and restricted mean survival times over the different time periods.

Results: 5671 participants were selected in time period 1, 6177 in period 2, and 6174 in period 3. Adjusted hazard ratios for all cause mortality between participants with and without atrial fibrillation were 1.9 (95% confidence interval 1.7 to 2.2) in time period 1, 1.4 (1.3 to 1.6) in period 2, and 1.7 (1.5 to 2.0) in period 3 (Ptrend=0.70). Ten years after diagnosis of atrial fibrillation, the adjusted difference in restricted mean survival times between participants with atrial fibrillation and matched referents decreased by 31%, from -2.9 years (95% confidence interval -3.2 to -2.5) in period 1, to -2.1 years (-2.4 to -1.8) in period 2, to -2.0 years (-2.3 to -1.7) in period 3 (Ptrend=0.03).

Conclusions: No evidence of a temporal trend in hazard ratios for the association between atrial fibrillation and all cause mortality was found. The mean number of life years lost to atrial fibrillation at 10 years had improved significantly, but a two year gap compared with individuals without atrial fibrillation still remained.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI), Framingham Heart Study, and the Boston University School of Medicine for the submitted work; LF reports grants from the Health Research Foundation of Central Denmark Region, personal fees from Bristol-Myers Squibb, personal fees from Pfizer, personal fees from Bayer, and personal fees from Merck Sharp and Dohme, outside of the submitted work. EJB serves as an uncompensated member of the MyHeartLab Steering Committee. The MyHeartLab Study is a principal investigator initiated study from the University of California San Francisco (UCSF): principal investigator Jeffrey Olgin, through a research grant to UCSF from Samsung. NV, QH, MF-G, and LT have no competing interests.

Figures

Fig 1
Fig 1
Temporal trends for the association between newly diagnosed atrial fibrillation and all cause mortality. Data are hazard ratios (95% confidence intervals) for the association between time varying atrial fibrillation and death (in participants with v those without atrial fibrillation). Multivariable models were adjusted for the clinical covariates listed in table 1. Linear trends across time periods were tested by meta-regression models of log hazard ratios
Fig 2
Fig 2
Adjusted survival curves for participants with atrial fibrillation and matched referents. Kaplan-Meier curves since time of diagnosis of atrial fibrillation for participants with atrial fibrillation and referents, matched on age at diagnosis of atrial fibrillation, sex, and Framingham Heart Study cohort, adjusted for clinical covariates at age of diagnosis of atrial fibrillation. The adjusted difference in the restricted mean survival time at 10 years between participants with atrial fibrillation and referents is the area between the survival curves: −2.85 years (95% confidence interval −3.21 to −2.50) in time period 1, −2.10 years (−2.35 to −1.84) in period 2, and −1.99 years (95% CI −2.26 to −1.72) in period 3 (Ptrend=0.03)

Similar articles

Cited by

References

    1. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154-62. 10.1016/S0140-6736(14)61774-8. - DOI - PMC - PubMed
    1. Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc 2017;6:e005155. 10.1161/JAHA.116.005155. - DOI - PMC - PubMed
    1. Martinez C, Katholing A, Wallenhorst C, Granziera S, Cohen AT, Freedman SB. Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. Heart 2015;101:1748-54. 10.1136/heartjnl-2015-307808. - DOI - PubMed
    1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47. 10.1161/CIRCULATIONAHA.113.005119. - DOI - PMC - PubMed
    1. Magnussen C, Niiranen TJ, Ojeda FM, et al. BiomarCaRE Consortium Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation 2017;136:1588-97. 10.1161/CIRCULATIONAHA.117.028981. - DOI - PMC - PubMed

Publication types